Daniel J. Curran

Insider Reports History

Entity
Individual
Location
828 Winter Street, Suite 300, Waltham, MA
Signature
/s/ Julia Walcott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel J. Curran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 25K Jun 14, 2024 Direct

Insider Reports Filed by Daniel J. Curran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 Director